Timothy Scannell

Timothy J.
Scannell is currently Chairman at Synaptive Medical, Inc. since 2023.
He is Independent Chairman at Insulet Corp.
since 2019, Independent Director at NovoCure Ltd. since 2021, Director at Regenity Biosciences since 2022, Director at Cerebral Therapeutics, Inc. since 2022, and Director at CereVasc, Inc. Former positions include Independent Non-Executive Director at Renalytix Plc from 2022 to 2023, Independent Director at MKUL, Inc. from 2022 to 2024, Independent Director at EXACT Sciences Corp.
from 2023 to 2024, Independent Director at Masimo Corp.
from 2024 to 2026, President & Chief Operating Officer at Stryker Corp.
from 2018 to 2021, President at Stryker Spine from 2003 to 2008, Vice President & General Manager at Stryker Biotech LLC from 2001 to 2003, Director at Entellus Medical, Inc., and Independent Director at AeroClean Technologies, Inc. Education includes an undergraduate degree (1986) and an MBA (1988) from the University of Notre Dame.